普雷西根生物 PGEN
$4.47 +$0.25 (+5.92%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $4.44 -0.67%
开盘$4.32
昨收$4.22
当日区间$4.03 – $4.48
成交量9.24M
市值$1.60B
市盈率（TTM）40.6
股息率–
财报
财报日平均波动±10.9%近16次财报
收涨次数12 / 1675% 的概率
最佳反应+25.6%
最差反应-5.8%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 4 Aug 2026 | After Market | ±19.9% | +5.51% | 符合区间 |
| 2026/Q1 | 13 May 2026 | After Market | ±13.9% | +10.84% | 符合区间 |
| 2025/Q4 | 25 Mar 2026 | After Market | ±21.0% | +25.48% | 超出定价预期 |
| 2025/Q3 | 13 Nov 2025 | After Market | ±10.9% | +25.65% | 超出定价预期 |
| 2024/Q4 | 19 Mar 2025 | After Market | ±27.7% | +0.56% | 符合区间 |
| 2024/Q2 | 14 Aug 2024 | After Market | ±92.9% | -4.46% | 符合区间 |
| 2024/Q1 | 14 May 2024 | After Market | ±18.5% | +5.11% | 符合区间 |
| 2023/Q4 | 19 Mar 2024 | After Market | ±34.8% | +0.00% | 符合区间 |
| 2023/Q2 | 9 Aug 2023 | After Market | ±121.0% | +22.58% | 符合区间 |
| 2023/Q1 | 10 May 2023 | After Market | ±111.6% | -5.79% | 符合区间 |
| 2022/Q4 | 6 Mar 2023 | After Market | ±119.1% | +17.39% | 符合区间 |
| 2022/Q3 | 9 Nov 2022 | After Market | ±74.8% | +21.09% | 符合区间 |
| 2022/Q2 | 8 Aug 2022 | After Market | ±41.5% | +12.68% | 符合区间 |
| 2022/Q1 | 9 May 2022 | After Market | ±117.4% | +12.17% | 符合区间 |
| 2021/Q4 | 1 Mar 2022 | Pre Market | ±26.7% | -4.00% | 符合区间 |
| 2021/Q2 | 9 Aug 2021 | None | ±28.7% | +0.72% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$54.98M+6,322.7% YoY
营业利润$22.64M+181.3% YoY
净利润$20.07M+175.3% YoY
摊薄每股收益$0.05+155.6% YoY
自由现金流-$18.20M+8.7% YoY
经营现金流-$17.81M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率90.7%
营业利润率-46.1%
净利率-392.8%
净资产收益率-9,907.5%
资产收益率-247.4%
投入资本回报率-597.7%
流动比率4.58
负债/资产比率74.4%
现金及投资$38.21M
总负债$97.29M
净现金（净负债）-$59.08M
暂无评论——快来第一个聊聊 PGEN。
登录后参与讨论。